
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Order Through Disorder: The Characteristic Variability of Systems
Yaron Ilan
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 53
Yaron Ilan
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 53
Showing 1-25 of 53 citing articles:
Molecular basis and biological function of variability in spatial genome organization
Elizabeth H. Finn, Tom Misteli
Science (2019) Vol. 365, Iss. 6457
Open Access | Times Cited: 254
Elizabeth H. Finn, Tom Misteli
Science (2019) Vol. 365, Iss. 6457
Open Access | Times Cited: 254
Using chronobiology-based second-generation artificial intelligence digital system for overcoming antimicrobial drug resistance in chronic infections
Yotam Kolben, Henny Azmanov, Ram Gelman, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 311-318
Open Access | Times Cited: 24
Yotam Kolben, Henny Azmanov, Ram Gelman, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 311-318
Open Access | Times Cited: 24
β-Glycosphingolipids as Mediators of Both Inflammation and Immune Tolerance: A Manifestation of Randomness in Biological Systems
Yaron Ilan
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 67
Yaron Ilan
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 67
Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy
Esther Forkosh, Ariel Kenig, Yaron Ilan
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 4
Open Access | Times Cited: 54
Esther Forkosh, Ariel Kenig, Yaron Ilan
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 4
Open Access | Times Cited: 54
Improving Global Healthcare and Reducing Costs Using Second-Generation Artificial Intelligence-Based Digital Pills: A Market Disruptor
Yaron Ilan
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 2, pp. 811-811
Open Access | Times Cited: 49
Yaron Ilan
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 2, pp. 811-811
Open Access | Times Cited: 49
A Subject-Tailored Variability-Based Platform for Overcoming the Plateau Effect in Sports Training: A Narrative Review
Ram Gelman, Marc Berg, Yaron Ilan
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1722-1722
Open Access | Times Cited: 36
Ram Gelman, Marc Berg, Yaron Ilan
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1722-1722
Open Access | Times Cited: 36
Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic Diseases
Yaron Ilan
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1303-1303
Open Access | Times Cited: 33
Yaron Ilan
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1303-1303
Open Access | Times Cited: 33
Microtubules as a potential platform for energy transfer in biological systems: a target for implementing individualized, dynamic variability patterns to improve organ function
Yaron Ilan
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 2, pp. 375-392
Closed Access | Times Cited: 29
Yaron Ilan
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 2, pp. 375-392
Closed Access | Times Cited: 29
Making use of noise in biological systems
Yaron Ilan
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 83-90
Closed Access | Times Cited: 21
Yaron Ilan
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 83-90
Closed Access | Times Cited: 21
A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trial
Ram Gelman, Noa Hurvitz, Rima Nesserat, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114334-114334
Open Access | Times Cited: 19
Ram Gelman, Noa Hurvitz, Rima Nesserat, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114334-114334
Open Access | Times Cited: 19
Overcoming Low Adherence to Chronic Medications by Improving their Effectiveness Using a Personalized Second-generation Digital System
Areej Bayatra, Rima Nasserat, Yaron Ilan
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 16, pp. 2078-2088
Closed Access | Times Cited: 5
Areej Bayatra, Rima Nasserat, Yaron Ilan
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 16, pp. 2078-2088
Closed Access | Times Cited: 5
The role of chronobiology in drug-resistance epilepsy: The potential use of a variability and chronotherapy-based individualized platform for improving the response to anti-seizure drugs
Assaf Potruch, Salim T. Khoury, Yaron Ilan
Seizure (2020) Vol. 80, pp. 201-211
Open Access | Times Cited: 48
Assaf Potruch, Salim T. Khoury, Yaron Ilan
Seizure (2020) Vol. 80, pp. 201-211
Open Access | Times Cited: 48
Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical Outcomes
Yaron Ilan
Frontiers in Digital Health (2020) Vol. 2
Open Access | Times Cited: 44
Yaron Ilan
Frontiers in Digital Health (2020) Vol. 2
Open Access | Times Cited: 44
Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided Algorithm
Ariel Kenig, Yotam Kolben, Rabea Asleh, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 38
Ariel Kenig, Yotam Kolben, Rabea Asleh, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 38
Platform introducing individually tailored variability in nerve stimulations and dietary regimen to prevent weight regain following weight loss in patients with obesity
Tawfik Khoury, Yaron Ilan
Obesity Research & Clinical Practice (2021) Vol. 15, Iss. 2, pp. 114-123
Closed Access | Times Cited: 32
Tawfik Khoury, Yaron Ilan
Obesity Research & Clinical Practice (2021) Vol. 15, Iss. 2, pp. 114-123
Closed Access | Times Cited: 32
Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response
Yaron Ilan
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 26
Yaron Ilan
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 26
The constrained disorder principle defines living organisms and provides a method for correcting disturbed biological systems
Yaron Ilan
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 6087-6096
Open Access | Times Cited: 25
Yaron Ilan
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 6087-6096
Open Access | Times Cited: 25
Digital Analgesic Comprising a Second-Generation Digital Health System: Increasing Effectiveness by Optimizing the Dosing and Minimizing Side Effects
Henny Azmanov, Areej Bayatra, Yaron Ilan
Journal of Pain Research (2022) Vol. Volume 15, pp. 1051-1060
Open Access | Times Cited: 24
Henny Azmanov, Areej Bayatra, Yaron Ilan
Journal of Pain Research (2022) Vol. Volume 15, pp. 1051-1060
Open Access | Times Cited: 24
Constrained disorder principle-based variability is fundamental for biological processes: Beyond biological relativity and physiological regulatory networks
Yaron Ilan
Progress in Biophysics and Molecular Biology (2023) Vol. 180-181, pp. 37-48
Closed Access | Times Cited: 15
Yaron Ilan
Progress in Biophysics and Molecular Biology (2023) Vol. 180-181, pp. 37-48
Closed Access | Times Cited: 15
The Constrained-Disorder Principle Assists in Overcoming Significant Challenges in Digital Health: Moving from “Nice to Have” to Mandatory Systems
Noa Hurvitz, Yaron Ilan
Clinics and Practice (2023) Vol. 13, Iss. 4, pp. 994-1014
Open Access | Times Cited: 13
Noa Hurvitz, Yaron Ilan
Clinics and Practice (2023) Vol. 13, Iss. 4, pp. 994-1014
Open Access | Times Cited: 13
Improving the response to lenvatinib in partial responders using a Constrained-Disorder-Principle-based second-generation artificial intelligence-therapeutic regimen: a proof-of-concept open-labeled clinical trial
Tal Sigawi, Ram Gelman, Ofra Maimon, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Tal Sigawi, Ram Gelman, Ofra Maimon, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
The Constrained Disorder Principle: Beyond Biological Allostasis
Ofek Adar, Josef Daniel Shakargy, Yaron Ilan
Biology (2025) Vol. 14, Iss. 4, pp. 339-339
Open Access
Ofek Adar, Josef Daniel Shakargy, Yaron Ilan
Biology (2025) Vol. 14, Iss. 4, pp. 339-339
Open Access
The Relationship Between Biological Noise and Its Application: Understanding System Failures and Suggesting a Method to Enhance Functionality Based on the Constrained Disorder Principle
Yaron Ilan
Biology (2025) Vol. 14, Iss. 4, pp. 349-349
Open Access
Yaron Ilan
Biology (2025) Vol. 14, Iss. 4, pp. 349-349
Open Access
Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistance
Yaron Ilan, Zachary Spigelman
Cancer Treatment and Research Communications (2020) Vol. 25, pp. 100240-100240
Open Access | Times Cited: 34
Yaron Ilan, Zachary Spigelman
Cancer Treatment and Research Communications (2020) Vol. 25, pp. 100240-100240
Open Access | Times Cited: 34
A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage
Yuval Ishay, Assaf Potruch, Asaf Schwartz, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112228-112228
Open Access | Times Cited: 30
Yuval Ishay, Assaf Potruch, Asaf Schwartz, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112228-112228
Open Access | Times Cited: 30